ELTROMBOPAG
NDC 70771-1925 · Zydus Lifesciences Limited
Generic nameeltrombopag
Dosage formTABLET
RouteORAL
Active ingredient(s)ELTROMBOPAG OLAMINE
Strength12.5 mg/1
Pharmacologic classBreast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]
Marketing categoryANDA
Packages
70771-1925-3 — 30 TABLET in 1 BOTTLE (70771-1925-3)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
69238-1416 — Eltrombopag, 69238-1417 — Eltrombopag, 70069-837 — Eltrombopag olamine, 70069-838 — Eltrombopag olamine, 70069-839 — Eltrombopag olamine, 70069-840 — Eltrombopag olamine, 70710-1395 — eltrombopag, 70710-1396 — eltrombopag, 70710-1397 — eltrombopag, 70710-1398 — eltrombopag, 70771-1926 — eltrombopag, 70771-1927 — eltrombopag, 70771-1928 — eltrombopag, 72205-156 — eltrombopag olamine, 72205-157 — eltrombopag olamine, 72205-158 — eltrombopag olamine, 72205-159 — eltrombopag olamine, 72865-299 — ELTROMBOPAG, 72865-300 — ELTROMBOPAG, 72865-301 — ELTROMBOPAG, +35 more